{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T18:09:20Z","timestamp":1786558160575,"version":"build-2736575974"},"reference-count":82,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>There is remarkable morphologic and genetic heterogeneity in acute myeloid leukemia (AML). In a small percentage of cases of AML, increased eosinophils and\/or basophils are present in the bone marrow and sometimes in the peripheral blood. This is often a puzzling diagnostic situation but also an important finding that requires special investigation. Unique chromosomal rearrangements have been correlated with an increased number of eosinophils and basophils in AML. The identification of the underlying genetic lesion that promotes eosinophilia and basophilia can dramatically change both the prognosis and the treatment of the patient. Thus, clinicians must be vigilant in searching for the cause of eosinophilia and basophilia in patients with AML, since the different causes may lead to different treatments and survival outcomes. In this article, we examine the significance of increased eosinophils and\/or basophils in the context of AML, provide guidance that simplifies the differential diagnosis, and give prognostic and therapeutic information about specific subtypes of AML associated with eosinophilia and\/or basophilia. Evidence supporting personalized (molecularly targeted) therapy for these patients is also presented.<\/jats:p>","DOI":"10.3390\/jcm13030876","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T09:42:32Z","timestamp":1706866952000},"page":"876","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Approach to Acute Myeloid Leukemia with Increased Eosinophils and Basophils"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2635-7441","authenticated-orcid":false,"given":"Stavros","family":"Papadakis","sequence":"first","affiliation":[{"name":"Department of Hematology, University Hospital of Heraklion, 711 10 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Liapis","sequence":"additional","affiliation":[{"name":"Department of Hematology, Aghios Georgios Hospital, 733 00 Chania, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanos I.","family":"Papadhimitriou","sequence":"additional","affiliation":[{"name":"Department of Laboratory Hematology, Georgios Gennimatas Hospital, 115 27 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4985-5862","authenticated-orcid":false,"given":"Emmanouil","family":"Spanoudakis","sequence":"additional","affiliation":[{"name":"Department of Hematology, Democritus University of Thrace Medical School, 681 00 Alexandroupolis, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kotsianidis","sequence":"additional","affiliation":[{"name":"Department of Hematology, Democritus University of Thrace Medical School, 681 00 Alexandroupolis, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1165-9639","authenticated-orcid":false,"given":"Konstantinos","family":"Liapis","sequence":"additional","affiliation":[{"name":"Department of Hematology, Democritus University of Thrace Medical School, 681 00 Alexandroupolis, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1182\/blood.V82.12.3515.3515","article-title":"Hematopoietic regulators: Redundancy or subtlety?","volume":"82","author":"Metcalf","year":"1993","journal-title":"Blood"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MOH.0000000000000552","article-title":"Transcription factor and cytokine regulation of eosinophil lineage commitment","volume":"27","author":"Mack","year":"2020","journal-title":"Curr. Opin. Hematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrc989","article-title":"Disruption of differentiation in human cancer: AML shows the way","volume":"3","author":"Tenen","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/(SICI)1097-0185(199811)252:3<418::AID-AR10>3.0.CO;2-1","article-title":"Eosinophil infiltration and degranulation in normal human tissue","volume":"252","author":"Kato","year":"1998","journal-title":"Anat. Rec."},{"key":"ref_5","unstructured":"Hoffman, R., Benz, E., Silberstein, L., Heslop, H., Weitz, J., Anastasi, J., and Salama, M. (2018). Hematology: Basic Principles and Practice, Elsevier."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Hoffbrand, V., Higgs, R., Keeling, D., and Mehta, A. (2016). Postgraduate Haematology, John Wiley & Sons.","DOI":"10.1002\/9781118853771"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"17406","DOI":"10.1074\/jbc.R113.546218","article-title":"Eosinophil granule proteins: Form and function","volume":"289","author":"Acharya","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ajh.26352","article-title":"World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Shomali","year":"2022","journal-title":"Am. J. Hematol."},{"key":"ref_10","first-page":"118","article-title":"Approach to eosinophilia","volume":"10","author":"Liapis","year":"2019","journal-title":"Haema"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/thx.41.7.503","article-title":"Charcot-Leyden crystals and Curschmann spirals in asthmatic sputum","volume":"41","author":"Sakula","year":"1986","journal-title":"Thorax"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/leu.2017.15","article-title":"Proposed diagnostic criteria and classification of basophilic leukemias and related disorders","volume":"31","author":"Valent","year":"2017","journal-title":"Leukemia"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.alit.2016.01.006","article-title":"Regulation of basophil and mast cell development by transcription factors","volume":"65","author":"Sasaki","year":"2016","journal-title":"Allergol. Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.1311668110","article-title":"GATA-1 regulates the generation and function of basophils","volume":"110","author":"Nei","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1182\/blood-2014-02-557983","article-title":"Transcription factor IRF8 plays a critical role in the development of murine basophils and mast cells","volume":"125","author":"Sasaki","year":"2015","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/blood-2011-12-399113","article-title":"Critical role of P1-Runx1 in mouse basophil development","volume":"120","author":"Mukai","year":"2012","journal-title":"Blood"},{"key":"ref_17","first-page":"148","article-title":"State-of-the-art review about basophil research in immunology and allergy: Is the time right to treat these cells with the respect they deserve?","volume":"10","author":"Chirumbolo","year":"2012","journal-title":"Blood Transfus."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bcmd.2005.08.006","article-title":"Uncommon phenotypes of acute myelogenous leukemia: Basophilic, mast cell, eosinophilic, and myeloid dendritic cell subtypes: A review","volume":"35","author":"Lichtman","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_19","first-page":"521","article-title":"Basophilic differentiation in acute promyelocytic leukemia","volume":"7","author":"Tallman","year":"1993","journal-title":"Leukemia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1128\/MCB.18.12.7432","article-title":"The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates","volume":"18","author":"Adya","year":"1998","journal-title":"Mol. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1128\/MCB.18.7.4252","article-title":"Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)\/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2\/CBFbeta-SMMHC fusion protein inhibits PEBP2\/CBF-mediated transactivation","volume":"18","author":"Kanno","year":"1998","journal-title":"Mol. Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1182\/blood.V87.6.2459.bloodjournal8762459","article-title":"The abnormal eosinophils are part of the leukemic cell population in acute myelomonocytic leukemia with abnormal eosinophils (AML M4Eo) and carry the pericentric inversion 16: A combination of May-Gr\u00fcnwald-Giemsa staining and fluorescence in situ hybridization","volume":"87","author":"Haferlach","year":"1996","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1182\/bloodadvances.2018016675","article-title":"Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation","volume":"2","author":"Xiao","year":"2018","journal-title":"Blood Adv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1182\/blood.V75.2.350.350","article-title":"In vitro differentiation of leukemic cells to eosinophils in the presence of interleukin-5 in two cases of acute myeloid leukemia with the translocation (8;21)(q22;q22)","volume":"75","author":"Ema","year":"1990","journal-title":"Blood"},{"key":"ref_26","first-page":"789","article-title":"Clonal eosinophils are a morphologic hallmark of ETV6\/ABL1 positive acute myeloid leukemia","volume":"87","author":"Trubia","year":"2002","journal-title":"Haematologica"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3324\/haematol.2016.144345","article-title":"Characterization of leukemias with ETV6-ABL1 fusion","volume":"101","author":"Zaliova","year":"2016","journal-title":"Haematologica"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Tirado, C.A., Siangchin, K., Shabsovich, D.S., Sharifian, M., and Schiller, G. (2016). A novel three-way rearrangement involving ETV6 (12p13) and ABL1 (9q34) with an unknown partner on 3p25 resulting in a possible ETV6-ABL1 fusion in a patient with acute myeloid leukemia: A case report and a review of the literature. Biomark. Res., 4.","DOI":"10.1186\/s40364-016-0070-7"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000342490","article-title":"Variant of ETV6\/ABL1 gene is associated with leukemia phenotype","volume":"129","author":"Park","year":"2013","journal-title":"Acta Haematol."},{"key":"ref_30","first-page":"614","article-title":"Myeloid\/lymphoid neoplasms with eosinophilia\/ basophilia and ETV6-ABL1 fusion: Cell-of-origin and response to tyrosine kinase inhibition","volume":"106","author":"Yao","year":"2021","journal-title":"Haematologica"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ajh.25825","article-title":"Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes","volume":"95","author":"Schwaab","year":"2020","journal-title":"Am. J. Hematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1128\/MCB.16.8.4107","article-title":"Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia","volume":"16","author":"Golub","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/gcc.1127","article-title":"Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping","volume":"31","author":"Odero","year":"2001","journal-title":"Genes. Chromosomes Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/sj.leu.2402158","article-title":"Further characterization of complex chromosomal rearrangements in myeloid malignancies: Spectral karyotyping adds precision in defining abnormalities associated with poor prognosis","volume":"15","author":"Odero","year":"2001","journal-title":"Leukemia"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/leu.2008.287","article-title":"Five years since the discovery of FIP1L1-PDGFRA: What we have learned about the fusion and other molecularly defined eosinophilias","volume":"22","author":"Gotlib","year":"2008","journal-title":"Leukemia"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1158\/0008-5472.CAN-06-4183","article-title":"Molecular mechanisms underlying FIP1L1-PDGFRA-mediated myeloproliferation","volume":"67","author":"Buitenhuis","year":"2007","journal-title":"Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/10428194.2016.1197396","article-title":"The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: An unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes","volume":"58","author":"Maccaferri","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3324\/haematol.2011.047530","article-title":"ETV6-PDGFRB and FIP1L1-PDGFRA stimulate human hematopoietic progenitor cell proliferation and differentiation into eosinophils: The role of nuclear factor-\u03baB","volume":"97","author":"Essaghir","year":"2012","journal-title":"Haematologica"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/bjh.17026","article-title":"International Working Group on Morphology of MDS. The role of eosinophil morphology in distinguishing between reactive eosinophilia and eosinophilia as a feature of a myeloid neoplasm","volume":"191","author":"Goasguen","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/ijlh.12057","article-title":"Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: A review","volume":"35","author":"Savage","year":"2013","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00000478-199203000-00003","article-title":"T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy","volume":"16","author":"Abruzzo","year":"1992","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_43","first-page":"72","article-title":"Myeloid\/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2","volume":"Volume 2","author":"Swerdlow","year":"2017","journal-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.humpath.2009.11.003","article-title":"8p11 myeloproliferative syndrome: A review","volume":"41","author":"Jackson","year":"2010","journal-title":"Hum. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3324\/haematol.2017.187302","article-title":"Molecular genetic characterization of myeloid\/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2","volume":"103","author":"Baer","year":"2018","journal-title":"Haematologica"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s12185-013-1337-5","article-title":"Acute myeloid leukemia associated with FGFR1 abnormalities","volume":"97","author":"Lee","year":"2013","journal-title":"Int. J. Hematol."},{"key":"ref_47","first-page":"135","article-title":"Acute leukemia with cytogenetically cryptic FGFR1 rearrangement and lineage switch during therapy: A case report and literature review","volume":"19","author":"McKeague","year":"2023","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1600-0609.2011.01672.x","article-title":"The 8p11 myeloid and lymphoid neoplasm","volume":"87","author":"Liapis","year":"2011","journal-title":"Eur. J. Haematol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.leu.2404662","article-title":"Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma","volume":"21","author":"Metzgeroth","year":"2007","journal-title":"Leukemia"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2141.2009.07746.x","article-title":"Acute myeloid leukaemia with associated eosinophilia: Justification for FIP1L1-PDGFRA screening in cases lacking the CBFB-MYH11 fusion gene","volume":"146","author":"Sorour","year":"2009","journal-title":"Br. J. Haematol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/leu.2009.2","article-title":"FIP1L1-PDGFRalpha D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRalpha T674I eosinophilic leukemia with single agent sorafenib","volume":"23","author":"Lierman","year":"2009","journal-title":"Leukemia"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00277-017-3067-x","article-title":"Imatinib in myeloid\/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase","volume":"96","author":"Jawhar","year":"2017","journal-title":"Ann. Hematol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: Integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/bloodadvances.2019001111","article-title":"Treatment-free remission in FIP1L1-PDGFRA-positive myeloid\/lymphoid neoplasms with eosinophilia after imatinib discontinuation","volume":"4","author":"Metzgeroth","year":"2020","journal-title":"Blood Adv."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e13000","DOI":"10.1111\/eci.13000","article-title":"The underestimated role of basophils in Ph+ chronic myeloid leukaemia","volume":"48","author":"Valent","year":"2018","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1182\/blood.V98.8.2580","article-title":"Detection of tryptase in cytoplasmic granules of basophils in patients with chronic myeloid leukemia and other myeloid neoplasms","volume":"98","author":"Samorapoompichit","year":"2001","journal-title":"Blood"},{"key":"ref_57","first-page":"3931","article-title":"Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia","volume":"59","author":"Nakayama","year":"1999","journal-title":"Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06866","article-title":"BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros","volume":"453","author":"Mullighan","year":"2008","journal-title":"Nature"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1182\/blood-2014-06-581173","article-title":"Disruption of IKAROS activity in primitive chronic-phase CML cells mimics myeloid disease progression","volume":"125","author":"Beer","year":"2015","journal-title":"Blood."},{"key":"ref_60","first-page":"164","article-title":"Acute myeloid leukaemia, NOS","volume":"Volume 2","author":"Swerdlow","year":"2017","journal-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues"},{"key":"ref_61","first-page":"1142","article-title":"Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia","volume":"7","author":"Drexler","year":"1993","journal-title":"Leukemia"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1182\/blood.V99.12.4326","article-title":"Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: Association with FAB subtypes and identification of subgroups with poor prognosis","volume":"99","author":"Thiede","year":"2002","journal-title":"Blood"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/10428190310001598053","article-title":"Acute basophilic leukemia with t(8;21)","volume":"45","author":"Seth","year":"2004","journal-title":"Leuk. Lymphoma"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1182\/blood-2012-07-442400","article-title":"Mast cell leukemia","volume":"121","author":"Lhermitte","year":"2013","journal-title":"Blood"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2141.1982.tb01910.x","article-title":"Acute promyelocytic leukaemia: A study of 39 cases with identification of a hyperbasophilic microgranular variant","volume":"50","author":"McKenna","year":"1982","journal-title":"Br. J. Haematol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12308-021-00469-1","article-title":"Case of acute promyelocytic leukemia with basophilic differentiation and an ETV6 mutation","volume":"14","author":"Ghimire","year":"2021","journal-title":"J. Hematop."},{"key":"ref_67","first-page":"437","article-title":"Uber Mastzellenleukamien","volume":"87","author":"Joachim","year":"1906","journal-title":"Dtsch. Arch. Kiln. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1586\/17474086.2014.942280","article-title":"Myelomastocytic leukemia: Histopathological features, diagnostic criteria and differential diagnosis","volume":"7","author":"Horny","year":"2014","journal-title":"Expert. Rev. Hematol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/10428199909167387","article-title":"Diagnosis of acute basophilic leukemia","volume":"32","author":"Duchayne","year":"1999","journal-title":"Leuk. Lymphoma"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/10428190601072293","article-title":"CD203c\/CD117-, an useful phenotype profile for acute basophilic leukaemia diagnosis in cases of undifferentiated blasts","volume":"48","author":"Didion","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1034\/j.1600-0609.2001.t01-1-00487.x","article-title":"Acute basophilic leukemia","volume":"67","author":"Giagounidis","year":"2001","journal-title":"Eur. J. Haematol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/003130200104592","article-title":"Acute basophilic leukemia presenting with abnormal liver function tests and the absence of blast cells in the peripheral blood","volume":"32","author":"Scolyer","year":"2000","journal-title":"Pathology"},{"key":"ref_73","first-page":"142","article-title":"Mast cell leukemia and acute basophilic leukemia. Cytochemical studies","volume":"45","author":"Liso","year":"1978","journal-title":"Bibl. Haematol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1182\/blood-2011-01-333013","article-title":"Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: A new entity in male infants","volume":"117","author":"Quelen","year":"2011","journal-title":"Blood"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/ccr3.1219","article-title":"Acute basophilic leukemia associated with the t(16;21)(p11;q22)\/FUS-ERG fusion gene","volume":"5","author":"Toda","year":"2017","journal-title":"Clin. Case Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1200\/JCO.2010.34.5710","article-title":"Acute basophilic leukemia associated with loss of gene ETV6 and protean complications","volume":"29","author":"Kritharis","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1111\/jcmm.16591","article-title":"Next-generation sequencing in two cases of de novo acute basophilic leukaemia","volume":"25","author":"Shimizu","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11154-016-9362-3","article-title":"Endocrine manifestations of systemic mastocytosis in bone","volume":"17","author":"Greene","year":"2016","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0002-9343(84)90864-7","article-title":"Acute basophilic leukemia","volume":"76","author":"Shah","year":"1984","journal-title":"Am. J. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/1097-0142(19950101)75:1<110::AID-CNCR2820750118>3.0.CO;2-I","article-title":"Acute basophilic leukemia in a child. Anaphylactoid reaction and coagulopathy secondary to vincristine-mediated degranulation","volume":"75","author":"Bernini","year":"1995","journal-title":"Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0016-5085(88)90311-3","article-title":"Basophilic leukemia and the hypersecretion of gastric acid and pepsin","volume":"95","author":"Anderson","year":"1988","journal-title":"Gastroenterology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.3892\/ol.2014.2544","article-title":"Acute basophilic leukemia presenting with maculopapular rashes and a gastric ulcer: A case report","volume":"8","author":"Luo","year":"2014","journal-title":"Oncol. Lett."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/3\/876\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:53:35Z","timestamp":1760104415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/3\/876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,2]]},"references-count":82,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["jcm13030876"],"URL":"https:\/\/doi.org\/10.3390\/jcm13030876","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,2]]}}}